IGFBP5 Regulates Adhesion-Driven Bortezomib Resistance in Multiple Myeloma
Researchers identified IGFBP5 as a negative regulator of adhesion-mediated bortezomib resistance in multiple myeloma that modulates FAK/Src signaling.
Researchers identified IGFBP5 as a negative regulator of adhesion-mediated bortezomib resistance in multiple myeloma that modulates FAK/Src signaling.
A new genetics-based framework systematically flags potential safety risks for inflammatory bowel disease drug targets before broad clinical exposure.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.